Apheresis Market Overview
The Apheresis Market focuses on technologies, equipment, disposable kits, and procedures used to separate specific components of blood from whole blood. Apheresis enables the selective collection or removal of plasma, platelets, red blood cells, or specific blood cells while returning the remaining components to the donor or patient. The technology is widely used for therapeutic procedures, blood component collection, plasma collection, and advanced applications such as cell and gene therapy manufacturing. The global Apheresis Market reached an estimated USD 4.18 billion in 2025 and is projected to grow to USD 9.45 billion by 2035, registering a CAGR of 8.5% during the forecast period 2026–2035.
Get Free Sample PDF Brochure:
https://www.marketresearchfuture.com/sample_request/1508
Market Drivers
Rising Prevalence of Autoimmune and Neurological Disorders:
The increasing prevalence of autoimmune and neurological disorders is a major factor driving demand for therapeutic apheresis. Conditions such as myasthenia gravis, Guillain-Barré syndrome, and chronic inflammatory demyelinating polyneuropathy may require plasma exchange or other apheresis-based therapies. Increasing clinical recognition of therapeutic apheresis is supporting procedure volumes worldwide.
Growing Demand for Blood Components:
The rising need for plasma, platelets, and other blood components is supporting the adoption of automated apheresis systems. Apheresis allows blood centers to collect targeted components efficiently and can support the growing requirements of hospitals, transfusion services, and pharmaceutical manufacturers.
Expansion of Cell and Gene Therapy:
The rapid development of cell and gene therapies is creating significant opportunities for the Apheresis Market. Leukapheresis is an important upstream step in the manufacturing of autologous cell therapies, including CAR-T treatments. As cell-based therapies continue to expand, demand for high-quality leukapheresis collections is expected to increase.
Technological Advancements in Apheresis Systems:
Modern apheresis platforms increasingly incorporate automation, real-time monitoring, advanced software, and improved collection technologies. Automated anticoagulation control, adaptive flow adjustments, and digital monitoring can improve procedure efficiency while supporting better donor and patient experiences.
Increasing Focus on Blood Safety:
Growing emphasis on blood safety and quality is encouraging healthcare systems and blood centers to modernize their collection infrastructure. The adoption of automated apheresis technologies can support standardized blood component collection and contribute to improved transfusion practices.
Rising Adoption of Single-Use Disposable Kits:
Single-use disposable kits are becoming increasingly important because they support infection-control practices and reduce cross-contamination risks. The recurring requirement for compatible collection kits also creates consistent demand within the Apheresis Market.
Market Challenges
High Capital Cost of Apheresis Equipment:
Automated apheresis systems require significant upfront investment, making adoption challenging for smaller hospitals and blood centers, particularly in developing economies. High equipment costs can restrict market penetration where healthcare budgets are limited.
Donor Adverse Reactions:
Apheresis procedures can result in donor reactions, including citrate-related symptoms such as tingling and muscle cramps. Although these reactions are generally manageable, concerns about donor comfort and repeat participation can affect collection programs.
Reimbursement Limitations:
Differences in reimbursement policies across countries and healthcare systems can limit the adoption of therapeutic apheresis procedures. Inadequate reimbursement may make it difficult for healthcare providers to recover the costs associated with equipment, trained staff, disposables, and procedure delivery.
Shortage of Skilled Professionals:
Apheresis procedures require trained healthcare professionals who understand specialized equipment, blood component separation, anticoagulation management, and patient or donor monitoring. A shortage of appropriately trained operators can restrict adoption, particularly in emerging markets.
Supply Chain Challenges for Disposable Products:
Apheresis systems depend on specialized disposable kits, tubing, collection sets, and processing components. Supply chain disruptions, manufacturing constraints, or shortages of compatible disposables can affect procedure volumes and healthcare facility operations.
Browse In-depth Market Research Report on Apheresis Market:
https://www.marketresearchfuture.com/reports/apheresis-market-1508
Market Segmentation
By Product Type:
Therapeutic Apheresis: Includes systems and technologies used to remove specific blood components or disease-associated substances from patients for therapeutic purposes.
Donor Apheresis: Used by blood collection organizations to selectively collect specific blood components from donors.
Plasma Apheresis: Designed primarily for the collection of plasma for transfusion and pharmaceutical applications.
Cell Apheresis: Used to collect specific cellular components, including leukocytes and other blood cells, for clinical and therapeutic applications.
By Application:
Renal Disorders: Apheresis can be used in selected renal-related conditions and specialized blood purification procedures.
Neurological Disorders: Therapeutic plasma exchange is utilized in several neurological conditions, supporting demand for apheresis systems.
Cancer Treatment: Apheresis supports certain oncology applications, including collection of cellular components and procedures associated with advanced cancer treatment.
Autoimmune Disorders: Increasing recognition of therapeutic plasma exchange in autoimmune conditions contributes to market growth.
By Procedure Type:
Manual Apheresis: Procedures in which blood separation involves greater manual intervention and operator control.
Automated Apheresis: Advanced systems use automated controls and monitoring to improve the efficiency, consistency, and safety of blood component separation.
By End User:
Hospitals: Hospitals represent a major end-user segment because of the increasing use of therapeutic apheresis for neurological, autoimmune, hematological, and other medical conditions.
Blood Donation Centers: Blood centers use apheresis technologies to collect plasma, platelets, and other blood components from donors.
Research Laboratories: Research laboratories utilize apheresis and cell-processing technologies for research, clinical studies, and cell therapy development.
By Region:
North America: Leading market supported by advanced blood banking infrastructure, high procedure volumes, established therapeutic apheresis programs, and strong adoption of advanced technologies.
Europe: Strong demand is supported by established healthcare systems, blood safety regulations, therapeutic apheresis protocols, and increasing adoption of specialized procedures.
Asia-Pacific: Rapidly growing region due to healthcare infrastructure development, increasing blood safety requirements, expanding donor programs, and rising healthcare investments.
South America: Growth is supported by investments in blood collection infrastructure, public healthcare programs, and modernization of transfusion services.
Middle East & Africa: Emerging opportunities are driven by healthcare modernization, increasing blood safety initiatives, and investments in advanced medical infrastructure.
Regional Insights
North America:
North America dominates the Apheresis Market with approximately 38% of global revenue. The United States represents the largest contributor due to high therapeutic apheresis procedure volumes, advanced blood banking infrastructure, established healthcare facilities, and increasing integration of apheresis into cell and gene therapy manufacturing.
Europe:
Europe holds a significant position in the global Apheresis Market, accounting for more than 28% of market revenue. Strong regulatory frameworks, established blood collection systems, and growing adoption of extracorporeal photopheresis and therapeutic apheresis are supporting regional demand.
Asia-Pacific:
Asia-Pacific is expected to be the fastest-growing regional market, with a projected CAGR of approximately 10.2% during 2026–2035. China and India are important growth markets as healthcare infrastructure improves, blood safety standards develop, and blood collection centers increasingly adopt automated apheresis systems.
Rest of the World:
South America, the Middle East, and Africa are emerging markets for apheresis technologies. Improvements in healthcare infrastructure, government investment in blood services, and increasing awareness of advanced blood component collection are expected to create new opportunities.
Key Players
Fresenius Kabi
Haemonetics Corporation
Terumo Blood and Cell Technologies
Asahi Kasei Medical
B. Braun Melsungen AG
Cerus Corporation
Kaneka Corporation
Miltenyi Biotec
Nikkiso Co., Ltd.
Mallinckrodt / Therakos
Future Outlook
The Apheresis Market is expected to experience strong growth through 2035 as healthcare systems increasingly adopt advanced blood component collection and therapeutic technologies. The market is projected to grow from USD 4.18 billion in 2025 to USD 9.45 billion by 2035, registering a CAGR of 8.5% during the forecast period.
The expansion of cell and gene therapy is expected to create an important growth opportunity because leukapheresis is an essential starting point for several autologous cellular therapies. At the same time, technological advancements in automation, artificial intelligence, real-time monitoring, and data-driven procedure optimization are expected to improve the performance of next-generation apheresis platforms.
The growing adoption of portable and decentralized collection models may further expand access to apheresis technology in rural and underserved areas. Increasing demand for plasma-derived medicines, platelet products, and specialized therapeutic procedures will also support market expansion.
Sustainability is expected to become increasingly important as healthcare providers seek ways to reduce waste associated with single-use apheresis products. Manufacturers are therefore likely to focus on improved packaging, recyclable materials, efficient product designs, and environmentally responsible manufacturing processes.
Strengthen your strategy with data-backed research insights:
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality and granular research to clients. Its market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country-level market segments enable clients to see more, know more, and do more, helping answer important business questions.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
